RESEARCHER PROFILE

Hanif Esmail

← Back to Institute of Infectious Disease and Molecular Medicine

H

Institute of Infectious Disease and Molecular Medicine

Tuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisCOVID-19 Clinical Research StudiesDiagnosis and treatment of tuberculosisHIV, TB, and STIs Epidemiology

Hanif Esmail works in Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, COVID-19 Clinical Research Studies, Diagnosis and treatment of tuberculosis, HIV, TB, and STIs Epidemiology. Recorded institutional associations include University of Cape Town, MRC Clinical Trials Unit at UCL, Wellcome Centre for Infectious Diseases Research in Africa.

118Publications
5,418Citations
32H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2021 · 1,976 citations

  2. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2021 · 533 citations

  3. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

    2021 · 492 citations

  4. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2022 · 369 citations

  5. The ongoing challenge of latent tuberculosis

    2014 · 325 citations

  6. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

    2022 · 324 citations

  7. Subclinical Tuberculosis Disease—A Review and Analysis of Prevalence Surveys to Inform Definitions, Burden, Associations, and Screening Methodology

    2020 · 312 citations

  8. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    2021 · 290 citations

  9. Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis

    2020 · 196 citations

  10. Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography

    2016 · 188 citations

  11. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise

    2024 · 171 citations

  12. Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

    2015 · 165 citations

  13. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

    2023 · 129 citations

  14. The Wonder Years: What Can Primary School Children Teach Us About Immunity to Mycobacterium tuberculosis?

    2018 · 128 citations

  15. The Immune Response toMycobacterium tuberculosisin HIV-1-Coinfected Persons

    2018 · 123 citations

  16. The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis

    2023 · 101 citations

  17. Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies

    2011 · 100 citations

  18. Tuberculosis Infectiousness and Host Susceptibility

    2017 · 100 citations

  19. Complement pathway gene activation and rising circulating immune complexes characterize early disease in HIV-associated tuberculosis

    2018 · 100 citations

  20. Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study

    2023 · 82 citations

  21. Mind the gap – Managing tuberculosis across the disease spectrum

    2022 · 65 citations

  22. Tuberculosis is changing

    2017 · 60 citations

  23. Tuberculosis transmission during the subclinical period: could unrelated cough play a part?

    2018 · 50 citations

  24. Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis

    2023 · 47 citations

  25. Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations

    2020 · 44 citations

← Return to the university profile